Zeya Xie Z et al
Gastrointestinal symptoms during dose changes Nausea, constipation, and other GI symptoms are the most common side effects of GLP-1 therapy, and they tend to re-emerge whenever dosing changes occur
ADM found 53% are snacking less during the mid-morning, 50% are snacking less in the mid-afternoon and 46% are cutting back late-night
Final Thoughts GLP-1 medications help control blood pressure through multiple pathwaysremoving excess salt, improving blood vessel function, releasing helpful hormones, and promoting weight loss
This section evaluates the available clinical evidence
the chemokine LEC liver- expressed chemokine, also known as NCC-4, HCC-4, or LMC LEC is chemotactic for dendritic cells, monocytes, T cells, NK cells and neutrophils and can therefore improve host-mediated anti-tumor responses